Seegenschmiedt Michael Heinrich
Klinik für Radioonkologie und Strahlentherapie, Alfried Krupp Krankenhaus, Essen.
MMW Fortschr Med. 2007 Jun 7;149(23):33-5. doi: 10.1007/BF03365075.
The current standard treatment for resectable tumours in clinical stages II and III is neoadjuvant radio(chemo)therapy. Improved radiation techniques and chemotherapy (CT) with continuous infusion of 5-FU during adjuvant radiotherapy (RT) has led to an additional improvement of adjuvant therapeutic results. The efficacy of new cytostatic drugs and antibodies is presently being clinically tested for perioperative therapy.
目前,临床II期和III期可切除肿瘤的标准治疗方法是新辅助放(化)疗。改进的放疗技术以及在辅助放疗期间持续输注5-氟尿嘧啶的化疗方法,进一步提高了辅助治疗效果。目前正在对新型细胞毒性药物和抗体在围手术期治疗中的疗效进行临床试验。